Advertisement

Advertisement

Departments

Advertisement

Advertisement



Aug
17
Today In Oncology
FDA Approves Fedratinib for Myelofibrosis
FDA Pipeline: Designation in CLL, New Drug Application in GIST, New Prostate Ablation System Receives 510(k) Clearance
Single-Institution Study of Next-Generation Sequencing Outcomes in Patients With Cancer
Circulating Tumor DNA and Relapse in Early-Stage Breast Cancer
Relapse of Nonseminomatous Germ Cell Tumors During Active Surveillance
View More 
;
Advertisement
Most Read Stories
Gender Equity
Fallopian Tube Removal May Protect Premenopausal Women at High Risk for Ovarian Cancer From Some Surgical Side Effects
Addition of Cediranib to Cisplatin/Pemetrexed in Chemotherapy-Naive Unresectable Malignant Pleural Mesothelioma
BEACON CRC: Encorafenib/Binimetinib/Cetuximab Improves Survival in BRAF V600E–Mutated Metastatic Colorectal Cancer
USPSTF Recommendation on Screening for Pancreatic Cancer in Asymptomatic Adults
View More 
Most Viewed Videos
Eric Jonasch, MD, on Kidney Cancer: A Year in Review
Jonathan E. Rosenberg, MD, on Urothelial Carcinoma: Adding Bevacizumab to Gemcitabine and Cisplatin
Michelle B. Riba, MD, on Screening for Distress in Cancer: Implementing the Standard of Care
Julie M. Vose, MD, MBA, on Lymphoma: Novel Pathways for Targeted Agents
Brian I. Rini, MD, on Renal Cell Cancer: Risk Stratification After Resection of Localized Disease
View More 
© 2019 HSP News Service, L.L.C.